MedscapeLIVE

🔥 VEXAS remains one of the most complex inflammatory hematologic syndromes. 💡 Explore management strategies with @beatalleukemia at Acute Leukemia Forum, April 16—17, 2026. #ALFlive26 🔗 mdsc.pe/47wfHri

🔥 Quick check: Are you confident managing CS long-term—beyond initial treatment? Fine-tune your approach to monitoring, therapy optimization, and multidisciplinary care. 🔗 mdsc.pe/3NqDxhu

🔍 Is surgery always the right first step for CSCC? 📖 Learn how to assess progression risk, identify patients who may not benefit from a surgical-first strategy, and build stronger multidisciplinary care plans. 📍 mdsc.pe/4bgYl2S

📊 New clinical data is redefining immunotherapy for solid tumors. Review trial results, explore the rationale for novel targets 🎯 , and assess strategies for integrating these therapies into evolving treatment paradigms. 👉 mdsc.pe/4l2qv5X

📊 New data. 💊 New therapies. 🩺 New possibilities in advanced BC care. Explore emerging clinical trial results and discover how to identify eligible patients and individualize treatment strategies. ➡ mdsc.pe/4bfTcrF

🎓 Training the next generation of pigmentary disorder experts. Explore emerging therapies, case discussions, and expert insights. 💡 Advance your clinical expertise. #PDElive26 👉 mdsc.pe/4b2Nue4

🧬 Severe aplastic anemia care is evolving. 🗯️ Explore treatment mechanisms, review emerging clinical trial data on cellular therapies, and learn how to identify patients who may benefit from these novel approaches. 👉 mdsc.pe/4rk1DIF

💥 Optimize treatment across the transplant journey. Review conditioning regimen evidence 📊, tackle unmet needs in steroid-refractory GvHD ⚠️, and strengthen personalized management plans 🤝 for patients and families. 👉 mdsc.pe/4cG6jEX

🧬 Optimizing IBD management? Explore evidence-based strategies for assessing disease severity, selecting therapies, and applying treat-to-target principles. 🎯 Elevate precision in care decisions. 🔗 mdsc.pe/407dMW4

🔍 Should CCUS and high-risk CH be treated like early MDS? 💡 Zoey Xie, MD, MS explores the emerging debate at Acute Leukemia Forum, April 16—17, 2026. #ALFlive26 🔗 mdsc.pe/47wfHri

💬 How do you explain the orexin system’s role in MDD to patients? Review the rationale, explore SORAs as an adjunctive strategy, and build confidence in translating this into real clinical conversations. 🔗 mdsc.pe/4sqmmvO

⚠️ Constipation ≠ IBS-C If you’re not separating the two correctly, you’re likely missing better treatment options. Get clear on diagnosis + evidence-based prescriptions that align with patient needs. 📍 mdsc.pe/3PiKhyn

💉 What makes an aesthetic treatment plan truly personalized? Discover how to perform a comprehensive aesthetic assessment and combine treatment approaches to address different skin layers and patient needs. 📌 mdsc.pe/4rlStLy

🔬 Optimize treatment across the transplant journey. Review conditioning regimen evidence 📊, tackle unmet needs in steroid-refractory GvHD ⚠️, and strengthen personalized management plans 🤝 for patients and families. 👉 mdsc.pe/4cG6jEX

Advance your thalassemia expertise: 🔍 Understand key pathophysiology linked to morbidity/mortality. 📊 Recognize variable burden and evolving patient needs. 💡 Explore novel therapy roles in TDT and NTDT. 👉 wb.md/49OBNpe

🔬 The future of psychiatry is evolving. Join expert faculty at the 25th Annual Psychopharmacology Update to explore treatment advances, psychedelics, and what’s next in care.📍 bit.ly/4rrN7yN #PsychPharm26

🧬 What role could Apelin signaling play in the future of AML therapy? Leonard Zon, MD shares new scientific perspectives shaping leukemia research at the Acute Leukemia Forum. 📅 April 16–17, 2026 | #ALFlive26 🔗 mdsc.pe/47wfHri

🚨 AHP doesn’t present the way you expect. 🧩 Symptoms can be vague, scattered, and easily missed. Level up your approach to recognition, lab testing, and understanding patient burden. 👉 mdsc.pe/4bjtlAw

🧠 Rethinking what’s possible in Parkinson disease. Explore the limitations of current PD therapies and early cell-based approaches—and dive into the mechanisms behind emerging cell therapies shaping the future of care. 🔬 Get the latest on ongoing clinical trials and what they mean for practice. 📍 Click here now: mdsc.pe/4aY17uE

📣 Invite your patients living with systemic mastocytosis An in-person Community Exchange with @KuykendallMd—designed for connection, shared experiences, and peer support in a safe, small-group setting. 🍽️ Dinner provided | Spots limited 🔗 mdsc.pe/40A4odX